Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Current State of the Clinical Applications of Artificial Intelligence in Stroke: A Literature Review
0
Zitationen
7
Autoren
2026
Jahr
Abstract
BACKGROUND: Artificial intelligence (AI) has emerged as a transformative tool in medicine, leveraging rapid analysis of large datasets to accelerate diagnosis, enhance clinical decision-making, and improve clinical workflows. This is highly relevant in stroke care given the time-sensitive nature of the disease process. This review evaluates the current landscape of evidence-based medicine utilizing AI in stroke, with emphasis on its use in phases of clinical care across the stroke continuum, including pre-hospital, acute, and recovery phases. This offers a comprehensive understanding of the current state of AI in both practice and literature. METHODS: A review of major databases was conducted, identifying peer-reviewed literature evaluating the use of AI and its level of evidence across the stroke continuum. Given the heterogeneity of study designs, interventions, and outcome metrics spanning multiple disciplines, findings were synthesized narratively. RESULTS: Across all phases of care, there remain no randomized controlled trials (RCTs) evaluating patient-level outcome data using AI (Level A). In the pre-hospital phase of care, AI has been used to identify stroke symptoms and assist EMS routing/training but presently remains limited to research. AI is most studied in the acute phase of care, representing the only phase to achieve commercial application in imaging detection and telestroke assistance, supported by non-randomized evidence (Level B-NR). In the recovery phase, AI may enhance wearable technologies, tele-rehabilitation, and robotics/brain-computer interfaces, with early RCTs (Level B-R) supporting the latter two, representing the strongest evidence for AI in stroke care to date. CONCLUSIONS: Despite the potential for AI to transform all phases of care across the stroke continuum, major challenges remain, including transparency, generalizability, equity, and the need for externally validated clinical studies.
Ähnliche Arbeiten
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
1993 · 12.198 Zit.
Correspondence - Tranexamic acid for traumatic brain injury
2005 · 11.737 Zit.
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 · 11.648 Zit.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.555 Zit.
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 · 10.211 Zit.